Differentiation of human mesenchymal stem cells: The potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation

American Journal of the Medical Sciences

Volumn 341, Issue 6, 2011, Pages 460-468

  Zhao, Jian Wu ^a   Gao, Zhong Li ^a   Mei, Hong ^b   Li, Yu Lin ^b   Wang, Yan ^b  

^a Department of Orthopaedics ^*  (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Adipocytes; Estrogen; Mesenchymal stem cells; Osteoblasts; Osteoporosis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CELL PROTEIN; ESTRADIOL; ESTROGEN; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SLINGSHOT 1L PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOPOROSIS; SIGNAL TRANSDUCTION;

EID: 79958134224     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31820865d5     Document Type: Article

References (33)

1. Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367: 2010-8. (Pubitemid 43867702)
2. Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone 2006;38:S4-9. (Pubitemid 43190767)
3. Raisz LG. Pathogenesis ofosteoporosis: concepts, conflicts, and pros-pects. J Clin Invest 2005;115:3318-25.
4. Ohta H, Masuzawa T, Ikeda T, et al. Which is more osteoporosis-inducing, menopause or oophorectomy? Bone Miner 1992;19:273-85.
5. Coelingh BHJ. Are all estrogens the same? Maturitas 2004;47:269-75.
6. Moriarty K, Kim KH, Bender JR. Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 2006;147:5557-63. (Pubitemid 44833471)
7. Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol 2008;3(suppl 3):S131-9.
8. Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys 2008;473:201-9.
9. Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchy-mal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25:2739-49. (Pubitemid 350127858)
10. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity ofbone? Nat Clin Pract Rheumatol 2006;2:35-43.
11. Beresford JN, Bennett JH, Devlin C, et al. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992;102(Pt 2):341-51.
12. Gimble JM, Morgan C, Kelly K, et al. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem 1995;58:393-402.
13. Muruganandan S, Roman AA, Sinal CJ. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009;66:236-53.
14. Lennon DP, Caplan AI. Isolation of human marrow-derived mesen-chymal stem cells. Exp Hematol 2006;34:1604-5. (Pubitemid 44548124)
15. Nishita M, Wang Y, Tomizawa C, et al. Phosphoinositide 3-kinase-mediated activation of cofilin phosphatase Slingshot and its role for insulin-induced membrane protrusion. J Biol Chem 2004;279:7193-8. (Pubitemid 38248866)
16. Wang Y, Shibasaki F, Mizuno K. Calcium signal-induced cofilin dephosphorylation is mediated by Slingshot via calcineurin. J Biol Chem 2005;280:12683-9.
17. Garcia-Olmo D, Garcia-Olmo DC Stem cells: promises andrealities in cancer research Clin Transl Oncol 2006;8:301-2.
18. Meunier P, Aaron J, Edouard C, et al. Osteoporosis and the replace-ment ofcell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971;80:147-54.
19. Jilka RL, Weinstein RS, Takahashi K, et al. Linkage ofdecreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996;97:1732-40. (Pubitemid 26105482)
20. Rodriguez JP, Garat S, Gajardo H, et al. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem 1999;75:414-23. (Pubitemid 29521650)
21. Kadiyala S, Young RG, Thiede MA, et al. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997;6:125-34. (Pubitemid 27188295)
22. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study ofestrogen-responsive cells in culture. Proc Natl Acad Sci USA 1986;83:2496-500. (Pubitemid 16026909)
23. Cheng SL, Yang JW, Rifas L, et al. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994;134:277-86. (Pubitemid 24021999)
24. Mikami Y, Asano M, Honda MJ, et al. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. J Cell Physiol 2010;223:123-33.
25. Franceschi RT, Iyer BS, Cui Y. Effects ofascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994;9:843-54. (Pubitemid 24178067)
26. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 2002;143:2349-56. (Pubitemid 34521581)
27. Robertson JF. Faslodex (ICI 182, 780), a novel estrogen receptor downregulator-future possibilities in breast cancer. J Steroid Biochem Mol Biol 2001;79:209-12. (Pubitemid 34158797)
28. Ebeling PR. Osteoporosis in men. New insights into aetiology, patho-genesis, prevention and management. Drugs Aging 1998;13:421-34. (Pubitemid 29002720)
29. Lecka-Czernik B, Gubrij I, Moerman EJ, et al. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR-gamma2. J Cell Biochem 1999;74:357-71. (Pubitemid 29344887)
30. Ohta Y, Kousaka K, Nagata-Ohashi K, et al. Differential activities, subcellular distribution and tissue expression patterns ofthree members of Slingshot family phosphatases that dephosphorylate cofilin. Genes Cells 2003;8:811-24. (Pubitemid 37304357)
31. Niwa R, Nagata-Ohashi K, Takeichi M, et al. Control of actin reorganization by Slingshot, a family ofphosphatases that dephosphor-ylate ADF/cofilin. Cell 2002;108:233-46. (Pubitemid 34161143)
32. Kratchmarova I, Blagoev B, Haack-Sorensen M, et al. Mechanism of divergent growth factor effects in mesenchymal stem cell differen-tiation. Science 2005;308:1472-7. (Pubitemid 40791302)
33. Takada I, Suzawa M, Matsumoto K, et al. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci 2007;1116:182-95. (Pubitemid 350274329)